생물학적 농약 시장 : 원료별, 작용 기전별, 제제별, 작물 유형별, 용도별 - 세계 예측(2026-2032년)

The Biorational Pesticides Market was valued at USD 8.73 billion in 2025 and is projected to grow to USD 9.59 billion in 2026, with a CAGR of 10.85%, reaching USD 17.96 billion by 2032.

An authoritative contextual overview that frames biorational pesticides in modern agriculture while orienting leaders toward strategic decision points and practical priorities

The biorational pesticide landscape is undergoing rapid refinement as growers, formulators, and regulators seek safer, more targeted crop protection options. This executive summary establishes the context for stakeholders who require a concise yet comprehensive synthesis of technological progress, regulatory developments, commercial dynamics, and operational implications across agricultural value chains. The evolution from broad-spectrum chemistries toward biologically derived and precision-applied solutions reflects growing demands for environmental stewardship, residue management, and integrated pest management compatibility.

In developing this narrative, we focus on actionable insights that bridge scientific advances and commercial realities. The sections that follow present a clear exposition of transformative shifts shaping the sector, the anticipated impact of policy measures in 2025, segmentation-driven opportunities, regional dynamics, competitive positioning, and pragmatic recommendations. Each component connects to practical decision points-product development priorities, supply chain resilience, channel strategies, and evidence-based advocacy-so that leaders can align resources with measurable objectives.

Ultimately, this introduction frames the report as a decision-support tool: it synthesizes complex information into prioritized actions and highlights areas where focused investment can generate outsized returns in sustainability, efficacy, and market differentiation.

A synthesis of converging technological, regulatory, and commercial forces driving product innovation supply chain evolution and differentiated go-to-market strategies

Several converging forces are reshaping the biorational pesticide landscape, producing opportunities for differentiation and new commercial models. Advances in formulation science, microbial strain selection, and pheromone deployment are increasing product specificity and consistency, which in turn improves field-level efficacy and farmer adoption. Concurrently, digital agronomy tools and precision application technologies enable more targeted deployments, reducing input volumes and supporting environmental compliance.

Regulatory frameworks are adapting to balance risk mitigation and innovation, which creates both compliance obligations and market openings for products that demonstrate low non-target effects and predictable degradation profiles. Investment patterns are shifting as venture and corporate capital focus on platform technologies and scalable manufacturing pathways for microbial and biochemical actives. As a result, novel partnerships are forming between traditional agrochemical firms, specialist biocontrol companies, contract manufacturing organizations, and precision agriculture providers.

In the supply chain, manufacturers are prioritizing formulation robustness and cold-chain logistics, while distributors emphasize service-based value propositions such as integrated pest management training and performance guarantees. These shifts collectively favor companies that can integrate scientific credibility, regulatory acumen, manufacturing reliability, and field-level support to deliver measurable agronomic outcomes.

How 2025 trade measures are reshaping supply chain resilience sourcing strategies and formulation priorities across the biorational pesticide value chain

Tariff actions and trade policy changes implemented in 2025 are exerting measurable influence on raw material sourcing, production economics, and end-user pricing dynamics within the biorational pesticides sector. Increased duties on certain agricultural inputs have prompted procurement teams to re-evaluate supplier portfolios, prioritize local or regional sourcing, and pursue dual-sourcing strategies to mitigate disruption. As logistics and customs processes adjust, manufacturers increasingly factor tariff volatility into contract terms and inventory planning.

These policy shifts also accelerate conversations around regional manufacturing investments. Firms with flexible manufacturing footprints can reposition production closer to demand centers to reduce tariff exposure and lead times. Conversely, companies reliant on specialized active ingredients from constrained geographies face tighter margins and may need to pass costs to customers or absorb them through efficiency improvements. Importantly, regulatory harmonization efforts and trade dialogues provide pathways to reduce friction, but they require sustained industry engagement and demonstrated compliance with environmental and safety standards.

From a market operations perspective, tariff-driven cost pressures have elevated the value of formulation efficiency and concentrated dosage formats that lower transportation weight and volume. Seed treatment and soil-applied modalities that reduce repeated applications can also become more attractive in cost-sensitive environments. Overall, tariffs in 2025 have catalyzed supply chain resilience measures and strategic investments that prioritize agility, local capabilities, and formulation innovation.

A segmentation-driven perspective that connects biological classes formulation types crop targets and application modes to prioritize development and commercialization pathways

Insightful segmentation clarifies where technical differentiation translates into commercial advantage and how portfolio design should align with application realities. The product taxonomy spans biochemical, botanical, and microbial categories, with biochemical solutions further differentiated into pheromones and plant extracts, botanical options including neem and pyrethrum, and microbial offerings characterized by bacteria, fungi, and viruses. Each of these biological classes presents distinct development timelines, registration pathways, and field efficacy profiles, and successful companies allocate R&D and regulatory resources accordingly.

Mode of action segmentation underscores the need for targeted performance claims and stewardship programs; bactericides, fungicides, herbicides, insecticides, and nematicides require tailored trial protocols and resistance management frameworks. Formulation choices influence distribution economics and on-farm usability, as emulsifiable concentrate formats, granular products, suspension concentrates, and wettable powders each interact differently with equipment, tank-mix partners, and shelf-life considerations. Crop type segmentation reveals where adoption drivers vary: cereals and grains often demand cost-effective, high-throughput solutions; fruits and vegetables prioritize residue profiles and consumer-facing safety; oilseeds and pulses need integrated protection compatible with rotation; and turf and ornamentals value aesthetic preservation and low phytotoxicity.

Application mode further refines go-to-market tactics, because foliar spray, seed treatment, soil treatment, and trunk injection each impose specific application windows, equipment requirements, and service models. Integrating these segmentation layers enables prioritization of development pipelines, regulatory strategies, and channel approaches that match technical attributes to farmer pain points and distributor capabilities.

Regional dynamics and regulatory diversity that drive differentiated adoption pathways commercialization approaches and localized value propositions across major global markets

Regional dynamics shape adoption curves, regulatory environments, and commercial models in distinct ways across major geographies. In the Americas, strong demand for sustainable inputs and advanced application technologies aligns with sizable distribution networks and a growing emphasis on integrated pest management adoption. North and South American growers often weigh cost pressures against sustainability commitments, creating fertile ground for products that demonstrate both agronomic performance and environmental benefits.

Europe, Middle East & Africa presents a heterogeneous policy and regulatory mosaic. Stricter environmental standards and proactive reduction targets have elevated interest in low-residue and specificity-driven products, while regulatory scrutiny increases the importance of robust safety dossiers. In regions within this cluster, smallholder and export-oriented farming systems require tailored value propositions emphasizing traceability and compliance with international buyer requirements.

Asia-Pacific exhibits rapid innovation adoption and dynamic market entry activity, driven by diverse cropping systems and rising demand for yield protection that aligns with sustainability goals. Here, local formulation capabilities and adaptable distribution channels are critical, and partnerships with agri-input distributors and service providers facilitate market penetration. Across all regions, companies that invest in local regulatory expertise, field trial networks, and channel training stand in the best position to convert technical promises into consistent on-farm outcomes.

Competitive positioning and value chain imperatives that define winners as those who integrate scientific platforms manufacturing scalability regulatory expertise and field-level service

Competitive positioning in the field of biorational pesticides favors organizations that combine scientific depth with scalable operations and market access. Established agrochemical firms are leveraging existing distribution networks and regulatory experience to expand biological portfolios, often through strategic partnerships, licensing agreements, or targeted acquisitions. At the same time, specialist biocontrol companies focus on platform technologies and niche applications where biological specificity and lower non-target impact create defensible market positions.

Contract development and manufacturing organizations play an increasingly pivotal role by enabling smaller innovators to reach commercial scale without upfront capital investment in production assets. Distributors and channel partners that provide agronomic advisory services and performance support differentiate themselves by reducing adoption barriers and strengthening farmer trust. Meanwhile, agritech firms supplying digital decision-support tools complement biological products by enabling optimized application timing and precision dosing, which enhances efficacy and sustainability.

For new entrants and incumbents alike, success requires a coherent value chain strategy: robust strain selection or active identification, validated formulation and stability, clear regulatory and stewardship pathways, and an allied channel capable of delivering training and performance measurement. Organizations that execute across these dimensions will secure higher retention among growers and deliver repeatable outcomes under diverse agronomic conditions.

A practical roadmap of prioritized investments and strategic partnerships to strengthen technical credibility supply chain agility and go-to-market effectiveness for biorational solutions

Industry leaders should adopt a multipronged approach that elevates product performance, supply chain robustness, and market-facing support. First, prioritize platform investments that improve active consistency and formulation stability while reducing cold-chain dependencies; these technical gains lower field variability and enhance distributor confidence. Second, build regulatory and stewardship capabilities early in development to shorten approval timelines and to demonstrate compliance with increasingly rigorous environmental criteria.

Third, pursue flexible manufacturing strategies that include regional contract manufacturing partnerships and modular production lines to mitigate geopolitical and tariff-related risks. This approach reduces lead times and protects margins in volatile trade environments. Fourth, strengthen channel propositions by offering agronomic training, outcome-based performance guarantees, and digital tools that support application timing and resistance management. These services accelerate adoption and create recurring revenue opportunities.

Finally, cultivate cross-sector collaborations that bring together formulation science, precision application providers, and farm advisory networks. Such alliances create integrated solutions that address grower pain points holistically and increase barriers to entry for competitors. By sequencing these actions-technical validation first, then regulatory clearance, followed by manufacturing scale-up and channel enablement-companies can accelerate commercialization while maintaining quality and compliance.

A transparent multi-source research approach that integrates laboratory validation field trials regulatory review and stakeholder interviews to produce actionable strategic guidance

The research underpinning this executive summary synthesizes peer-reviewed literature, regulatory filings, patent landscapes, field trial reports, and primary interviews with R&D leaders, supply chain managers, and channel partners. Data integrity is ensured through cross-validation of technical claims against independent agronomic trial results and regulatory documentation, and by triangulating qualitative insights from multiple stakeholder interviews. Where possible, laboratory performance data was corroborated with supervised field evaluations to ensure practical relevance.

Analytical methods combine qualitative thematic analysis with comparative assessment frameworks that evaluate product attributes across efficacy, environmental profile, application compatibility, and supply chain implications. Scenario analysis was applied to assess impacts of policy shifts and trade measures on sourcing and manufacturing decisions, and sensitivity checks validated the robustness of strategic recommendations. Throughout the process, emphasis remained on translating technical complexity into operationally relevant guidance for product developers, supply chain leaders, and commercial teams.

This methodology supports actionable conclusions while acknowledging inherent uncertainties in biological systems and evolving regulatory priorities, and it privileges evidence-based recommendations that are adaptable to changing agronomic and policy contexts.

A concise synthesis that links technological promise regulatory dynamics and operational readiness to define competitive pathways for predictable and scalable biorational solutions

In summary, the biorational pesticide sector stands at an inflection point where scientific innovation, regulatory evolution, and commercial pragmatism intersect to create meaningful opportunities for firms that can deliver consistent, targeted, and environmentally responsible solutions. The most promising pathways prioritize formulation robustness, scalable manufacturing, regulatory foresight, and channel enablement that together reduce adoption friction and amplify field-level performance. Transitional technologies such as pheromones, microbial platforms, and plant-derived actives are moving from experimental stages into commercial application where their value is realized through integrated service models and precision application.

Policy shifts and tariff dynamics in 2025 have accelerated strategic reassessments around sourcing and production footprints, encouraging investments in regional capabilities and formulation efficiency. Companies that respond with agility-investing in local regulatory expertise, forming strategic manufacturing partnerships, and delivering strong channel support-will secure competitive advantage. Ultimately, success in this sector will be defined by the ability to translate biological promise into predictable agronomic outcomes and to deliver those outcomes at scale while meeting evolving environmental and food safety expectations.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biorational Pesticides Market, by Source

• 8.1. Biochemical
  • 8.1.1. Pheromones
  • 8.1.2. Plant Extracts
• 8.2. Botanical
  • 8.2.1. Neem
  • 8.2.2. Pyrethrum
• 8.3. Microbial
  • 8.3.1. Bacteria
  • 8.3.2. Fungi
  • 8.3.3. Viruses

9. Biorational Pesticides Market, by Mode Of Action

• 9.1. Bactericide
• 9.2. Fungicide
• 9.3. Herbicide
• 9.4. Insecticide
• 9.5. Nematicide

10. Biorational Pesticides Market, by Formulation

• 10.1. Emulsifiable Concentrate
• 10.2. Granules
• 10.3. Suspension Concentrate
• 10.4. Wettable Powder

11. Biorational Pesticides Market, by Crop Type

• 11.1. Cereals & Grains
• 11.2. Fruits & Vegetables
• 11.3. Oilseeds & Pulses
• 11.4. Turf & Ornamentals

12. Biorational Pesticides Market, by Application

• 12.1. Foliar Spray
• 12.2. Seed Treatment
• 12.3. Soil Treatment
• 12.4. Trunk Injection

13. Biorational Pesticides Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. Biorational Pesticides Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Biorational Pesticides Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. United States Biorational Pesticides Market

17. China Biorational Pesticides Market

18. Competitive Landscape

• 18.1. Market Concentration Analysis, 2025
  • 18.1.1. Concentration Ratio (CR)
  • 18.1.2. Herfindahl Hirschman Index (HHI)
• 18.2. Recent Developments & Impact Analysis, 2025
• 18.3. Product Portfolio Analysis, 2025
• 18.4. Benchmarking Analysis, 2025
• 18.5. Adama Agricultural Solutions Ltd
• 18.6. Andermatt Biocontrol AG
• 18.7. BASF SE
• 18.8. Bayer AG
• 18.9. Biobest Group
• 18.10. Bionema Limited
• 18.11. Bioworks Inc
• 18.12. Certis Biologicals
• 18.13. Corteva Agriscience
• 18.14. FMC Corporation
• 18.15. Gowan Company
• 18.16. Isagro S.p.A.
• 18.17. Koppert Biological Systems B.V.
• 18.18. Lallemand Inc
• 18.19. Nufarm Ltd
• 18.20. PI Industries Ltd
• 18.21. Russell IPM Ltd
• 18.22. Sumitomo Chemical Co Ltd
• 18.23. Suterra Inc
• 18.24. Syngenta AG
• 18.25. UPL Limited
• 18.26. Valent BioSciences LLC
• 18.27. Vestaron Corporation